-
Biopharma Suppliers’ Budgets Increase: Bellwether for Better Times: Biopharmaceutical companies have weathered a rough recession, layoffs, and budget trimmings. These cutbacks have affected their vendors as well. In BioPlan Associates’ 8th Annual Report and Survey of Biopharmaceutical Manufacturing, we surveyed 352 biotherapeutic manufacturers, and 180 of their vendors, in 32 countries. The substantial budget cuts at vendors that started in 2008 have begun to turn around. We measured 10 budget areas for vendors to this industry. Sales budgets, the only area that did not take a downturn, continued to increase, this year, by an average of 5% globally. read more
eric langer | manufacturing | surve
-
Single Use Device Adoption Impacted by Slow Standards Setting: Leachables and extractables category, (which also leads the 2011 list of Factors Restricting Use of Disposables) are a key concern. Worries over “leachables and extractables” have increased for both groups over the past 4 years. read more
Eric Langer | BioPlan Associates | leachables
-
Higher Tech Outsourcing Repositions CMOs: While many biomanufacturers continue to view outsourcing as part of their cost reduction approach, more are considering how they can incorporate outsourcing of the technical more complex upstream and downstream operations as part of their business strategy. If biopharma companies hold to these plans, the outsourcing arena may change considerably over the next few years. read more
Eric Langer | biomanufacturing | outsourcing
-
Single Use Bioreactors Lead in New Use and Market Penetration: Single use technologies are strong change agents in biopharma manufacturing. Disposable devices emerge once again as a top new technology of interest among the 352 surveyed biomanufacturers in BioPlan Associates, Inc.’s 2011 8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production. read more
Eric Langer | single use bioreactors | biopharma manufacturing
-
BioPharma Budget Bump—2011 Sees Spending Upswing: Budgets for the biomanufacturing sector of biotech show a significant upswing from recent years’ freezes and cuts. In fact, respondents to BioPlan’s 8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production projected only increases in 2011. This budget bump reverses the previous 2 years’ slashes. While a single year does not define ongoing trends, responses register a positive change from recession-reduced allocations in all areas. read more
Eric Langer | BioPlan Associates | Inc
Advertisement
Events of Interest
-
Global Pharmaceutical Distribution 2012
Venue to be Confirmed, Amsterdam, The Netherlands
September 18- 19, 2012 -
Cool Chain Logistics 2013
Congress Center Basel, Basel, Switzerland
January 28- 30, 2013 -
Information Governance & eDiscovery for Pharma, Biotech and Medical Devices
London, UK
June 26- 28, 2012 -
Cold Chain Global Forum 2012
Chicago, IL
September 24- 28, 2012
Articles
-
Contributor: Andrea Charles
Global Clinical Outsourcing Forum – Avoids Death by PowerPoint with New Format – Round Up: GCOF took brave step this year and was un-conferenced. The 3rd Annual Global Cli... read more
Tags: clinical outsourcing | global clinical outsourcing | Global Clinical Outsourcing Forum
-
Contributor: Joe Liscouski
Smooth the Path to Integration in Informatics: With an increasing emphasis on informatics and the potential to better organize and manage... read more
Tags: Informatics | Standards | integration
-
Contributor: Niamh Madigan
6 Tips to Achieving the Impossible in the Face of Change: Let’s face it, we live in a world that is constantly changing and nowhere ... read more
Tags: change | impossible | possible
-
Contributor: Runa Mookerjee
US Healthcare Regulation, Technology Advancements Spell Boom for Outsourcing: Advancements in healthcare technology, apart from improvement of quality of care, are almo... read more
Tags: electronic medical record | EMR | electronic health record
-
Contributor: James Harris
Biosimilars Landscape and FDA Regulatory Expectations: The Congressional Budget Office (CBO) has estimated that the United States could save $25 ... read more
Tags: biosimilars | FDA | FDA regulatory expectations
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2012 All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us |
|
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!